Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 27, 2024
Accession Number: 0001213900-24-111996
Submission Type: POS AM
CIK: 0001191070
Company Name: Neuphoria Therapeutics Inc.
File Number: 333-280288